Switch theme
Sign up to access all valuation multiples
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
1905
109K+
LTM Revenue $84.7B
LTM EBITDA $23.4B
$388B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Procter & Gamble has a last 12-month revenue (LTM) of $84.7B and a last 12-month EBITDA of $23.4B.
In the most recent fiscal year, Procter & Gamble achieved revenue of $84.3B and an EBITDA of $23.9B.
Procter & Gamble expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Procter & Gamble valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $84.7B | XXX | $84.3B | XXX | XXX | XXX |
| Gross Profit | $43.3B | XXX | $43.1B | XXX | XXX | XXX |
| Gross Margin | 51% | XXX | 51% | XXX | XXX | XXX |
| EBITDA | $23.4B | XXX | $23.9B | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 28% | XXX | XXX | XXX |
| EBIT | $20.5B | XXX | $20.5B | XXX | XXX | XXX |
| EBIT Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $16.8B | XXX | $16.0B | XXX | XXX | XXX |
| Net Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $25.0B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Procter & Gamble's stock price is $154.
Procter & Gamble has current market cap of $362B, and EV of $388B.
See Procter & Gamble trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $388B | $362B | XXX | XXX | XXX | XXX | $6.85 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Procter & Gamble has market cap of $362B and EV of $388B.
Procter & Gamble's trades at 4.6x EV/Revenue multiple, and 16.7x EV/EBITDA.
Equity research analysts estimate Procter & Gamble's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Procter & Gamble has a P/E ratio of 21.5x.
See valuation multiples for Procter & Gamble and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $362B | XXX | $362B | XXX | XXX | XXX |
| EV (current) | $388B | XXX | $388B | XXX | XXX | XXX |
| EV/Revenue | 4.6x | XXX | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | 16.6x | XXX | 16.7x | XXX | XXX | XXX |
| EV/EBIT | 18.9x | XXX | 19.3x | XXX | XXX | XXX |
| EV/Gross Profit | 9.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 21.5x | XXX | 23.4x | XXX | XXX | XXX |
| EV/FCF | 30.9x | XXX | 25.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialProcter & Gamble's last 12 month revenue growth is 3%
Procter & Gamble's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.2M for the same period.
Procter & Gamble's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Procter & Gamble's rule of X is 36% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Procter & Gamble and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | 31% | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 36% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Procter & Gamble acquired XXX companies to date.
Last acquisition by Procter & Gamble was XXXXXXXX, XXXXX XXXXX XXXXXX . Procter & Gamble acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Procter & Gamble founded? | Procter & Gamble was founded in 1905. |
| Where is Procter & Gamble headquartered? | Procter & Gamble is headquartered in United States of America. |
| How many employees does Procter & Gamble have? | As of today, Procter & Gamble has 109K+ employees. |
| Who is the CEO of Procter & Gamble? | Procter & Gamble's CEO is Mr. Jon R. Moeller. |
| Is Procter & Gamble publicy listed? | Yes, Procter & Gamble is a public company listed on NYS. |
| What is the stock symbol of Procter & Gamble? | Procter & Gamble trades under PG ticker. |
| When did Procter & Gamble go public? | Procter & Gamble went public in 1950. |
| Who are competitors of Procter & Gamble? | Similar companies to Procter & Gamble include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group. |
| What is the current market cap of Procter & Gamble? | Procter & Gamble's current market cap is $362B |
| What is the current revenue of Procter & Gamble? | Procter & Gamble's last 12 months revenue is $84.7B. |
| What is the current revenue growth of Procter & Gamble? | Procter & Gamble revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Procter & Gamble? | Current revenue multiple of Procter & Gamble is 4.6x. |
| Is Procter & Gamble profitable? | Yes, Procter & Gamble is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Procter & Gamble? | Procter & Gamble's last 12 months EBITDA is $23.4B. |
| What is Procter & Gamble's EBITDA margin? | Procter & Gamble's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Procter & Gamble? | Current EBITDA multiple of Procter & Gamble is 16.6x. |
| What is the current FCF of Procter & Gamble? | Procter & Gamble's last 12 months FCF is $12.6B. |
| What is Procter & Gamble's FCF margin? | Procter & Gamble's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Procter & Gamble? | Current FCF multiple of Procter & Gamble is 30.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
